-
New antibody for effective blood cancer treatment using two-pronged approach
biospectrumasia
June 23, 2017
The findings of multiple in vivo preclinical studies indicate that this therapy could potentially treat multiple cancers.
-
Biontech brings antibody production into the body
epvantage
June 13, 2017
Antibodies have transformed the treatment landscape in many diseases, but are time-consuming and expensive to make. Prod
-
Innate Pharma acquires anti-C5aR antibody from Novo Nordisk
pharmaceutical-technology
June 06, 2017
French biotechnology company Innate Pharma has signed an agreement to acquire a clinical-stage anti-C5a receptor (C5aR) antibody (IPH5401) from Danish pharmaceutical firm Novo Nordisk for €40m.
-
EUSA Pharma receives EC approval for dinutuximab beta antibody to treat neuroblastoma
pharmaceutical-technology
May 11, 2017
EUSA Pharma has secured European Commission (EC) approval for the antibody ch14.18/CHO, (dinutuximab beta) to be used in treating high-risk neuroblastoma in patients older than a year.
-
Crown Bioscience Enters Antibody Collaboration
contractpharma
May 10, 2017
Crown Bioscience will collaborate to develop a cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody with Jiangsu Qyun Bio-Pharmaceutical.
-
Cobra Biologics Helps Alligator Bio Complete Phase I Trial
contractpharma
April 14, 2017
maxXpress platform used to enable rapid and high-yielding expression of protein ADC-1013
-
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
americanpharmaceuticalreview
April 14, 2017
Roche has announced the global launch of the anti-p504s (SP116) Rabbit Monoclonal Primary Antibody2 for prostate cancer diagnosis.
-
Innova Biosciences introduces Biotin Check&Go! Kit
cphi-online
April 06, 2017
Kit for confirming successful antibody-biotin conjugation.
-
NBE-Therapeutics Expands Board of Directors by the Appointment of Hans-Peter Gerber
b3cnewswire
April 05, 2017
NBE Therapeutics AG, a biopharmaceutical company developing next generation ADC products based on its Transpo-mAb™ antibody platform...
-
MRC Technology licenses antibody to Newsummit Biopharma for development of Hepatitis C virus infecti
pharmaasia
March 27, 2017
MRC Technology announced it has licensed an antibody to Newsummit Biopharma for development of a novel therapeutic for treatment of Hepatitis C virus (HCV) infection.